Literature DB >> 3001705

Multistep transformation by defined fragments of herpes simplex virus type 2 DNA: oncogenic region and its gene product.

Y Hayashi, T Iwasaka, C C Smith, L Aurelian, G K Lewis, P O Ts'o.   

Abstract

Diploid Syrian hamster embryo cells transfected with Bgl II C fragment of herpes simplex virus type 2 DNA acquired a neoplastic phenotype. Cultures transfected with its left-hand 64% subclone EcoRI/HindIII fragment AE (0.419-0.525 map unit) grew into established but nontumorigenic lines. Transfection of EcoRI/HindIII AE-immortalized cells with a 4.4-kilobase Sac I/BamHI subfragment within BamHI E (0.554-0.584 map unit; overlaps the right-hand 16% of Bgl II C) converted them to tumorigenicity. The 4.4-kilobase subfragment encodes a 144-kDa protein immunologically and structurally similar to an infected cell protein designated ICP 10. DNA extracted from cells transformed with the 4.4-kilobase subfragment exhibited discrete hybridizing bands homologous to BamHI E fragment. Monoclonal antibody to ICP 10 precipitated a 144-kDa protein from the transformed cells and stained them in immunofluorescence. A tumor derivative established with the transformed cells did not stain with this antibody, but approximately equal to 25% of the cells stained with a monoclonal antibody to c-myc protooncogene products.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001705      PMCID: PMC390942          DOI: 10.1073/pnas.82.24.8493

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

Authors:  C B Lozzio; B B Lozzio
Journal:  Blood       Date:  1975-03       Impact factor: 22.113

2.  Organization of the left-hand end of the herpes simplex virus type 2 BglII N fragment.

Authors:  D A Galloway; M A Swain
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

3.  Immortalization and neoplastic transformation of normal diploid cells by defined cloned DNA fragments of herpes simplex virus type 2.

Authors:  R J Jariwalla; L Aurelian; P O Ts'o
Journal:  Proc Natl Acad Sci U S A       Date:  1983-10       Impact factor: 11.205

4.  Expression of region E1b of human adenoviruses in the absence of region E1a is not sufficient for complete transformation.

Authors:  P Van den Elsen; A Houweling; A Van der Eb
Journal:  Virology       Date:  1983-07-30       Impact factor: 3.616

5.  Isolation of high-molecular-weight DNA from mammalian cells.

Authors:  M Gross-Bellard; P Oudet; P Chambon
Journal:  Eur J Biochem       Date:  1973-07-02

6.  Herpes simplex virus sequences involved in the initiation of oncogenic morphological transformation of rat cells are not required for maintenance of the transformed state.

Authors:  I R Cameron; M Park; B M Dutia; A Orr; J C Macnab
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

7.  Immunological characterization of herpes simplex virus type 1 and 2 polypeptide(s) involved in viral ribonucleotide reductase activity.

Authors:  S Bacchetti; M J Evelegh; B Muirhead; C S Sartori; D Huszar
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

8.  c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells.

Authors:  S R Hann; C B Thompson; R N Eisenman
Journal:  Nature       Date:  1985 Mar 28-Apr 3       Impact factor: 49.962

9.  The protein encoded by the human proto-oncogene c-myc.

Authors:  G Ramsay; G I Evan; J M Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

10.  DNA sequence homology between two co-linear loci on the HSV genome which have different transforming abilities.

Authors:  J McLauchlan; J B Clements
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  9 in total

1.  Genomic sequences homologous to the protein kinase region of the bifunctional herpes simplex virus type 2 protein ICP10.

Authors:  C C Smith; J P Wymer; J Luo; L Aurelian
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

2.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  M A Ali; D McWeeney; A Milosavljevic; J Jurka; R J Jariwalla
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

3.  Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  J P Wymer; T D Chung; Y N Chang; G S Hayward; L Aurelian
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Protein kinase activity associated with the large subunit of herpes simplex virus type 2 ribonucleotide reductase (ICP10).

Authors:  T D Chung; J P Wymer; C C Smith; M Kulka; L Aurelian
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

5.  The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.

Authors:  P Desai; R Ramakrishnan; Z W Lin; B Osak; J C Glorioso; M Levine
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

6.  Localization and comparative nucleotide sequence analysis of the transforming domain in herpes simplex virus DNA containing repetitive genetic elements.

Authors:  C Jones; J Ortiz; R J Jariwalla
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  DNA amplification and neoplastic transformation mediated by a herpes simplex DNA fragment containing cell-related sequences.

Authors:  R J Jariwalla; B Tanczos; C Jones; J Ortiz; S Salimi-Lopez
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

Review 8.  Cervical cancer: is herpes simplex virus type II a cofactor?

Authors:  C Jones
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

9.  Characterization of the novel protein kinase activity present in the R1 subunit of herpes simplex virus ribonucleotide reductase.

Authors:  J Cooper; J Conner; J B Clements
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.